JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Specifically, ICA regulates the Jak2/Stat3/p21 signaling pathway, increases the accumulation of reactive oxygen species (ROS), and induces senescence in IM‐resistant cells, thereby suppressing the malignant progression of CML [67].